AVICHAI "AVI" KREMER, Chief Executive Officer, is a co-founder of Prize4Life, Inc. and former Chairman of the Board. Kremer was diagnosed with ALS in 2004 and since then he has worked as the CEO of an ALS nonprofit, IsrALS • the Israeli ALS Association, where he raised funds to launch multiple ALS research projects in Israel. He has also worked to promote ALS research at the Harvard Center for Neurodegeneration and Repair and the Massachusetts General Hospital. Before attending Harvard, Kremer was a project manager for Elbit Systems, Ltd. Previously Kremer was a Captain in the Israeli Defense Force. Kremer holds an MBA from the Harvard Business School and his B.A. degree in Computer Science from the Technion Israel Institute of Technology. Kremer was recognized in 2006 with the Harvard Business School's prestigious Dean's Award for making an outstanding contribution to Harvard and society.
MEGHAN KALLMAN is Prize4Life's Marketing and Communications Manager. Prior to joining Prize4Life in 2009, Meghan served as Project Director at the Proyecto mARTado, in Cochabamba, Bolivia, and has been a writer, consultant, and research assistant for various non-profit organizations. She has done extensive work in grassroots organizing and communications both at home and abroad, with particular time spent in Latin America. Meghan earned a MA in Political Sociology from the University of Chicago and a BA in Sociology from Smith College.
BROOKE LARIMER is Prize4Life's Manager of Operations and Administration. Prior to joining Prize4Life, Brooke served as Accounts Payable Accounting Assistant at The Boston Conservatory, co-founded Boston Opera Collaborative where she also served as President and Public Relations Chair, and served as a legal assistant to the firm Pyle, Rome, Lichten, Ehrenberg & Liss-Riordan, P.C. She received her M.Mus. in Voice Performance from The Boston Conservatory and her B.Mus., magna cum laude in Voice Performance from Vanderbilt University. Outside of her work at Prize4Life, she maintains a busy private voice studio and active performing career.
DR. MELANIE LEITNER, Ph.D., is Chief Operating Officer and Chief Scientific Officer for Prize4Life. Prior to Prize4Life, she served as Program Officer for JGPerpich, LLC, a small consulting firm focused on developing and using information technologies to promote collaborations in biomedical research, services, and education, particularly in the neuroscience and mental health fields. She has also held Director positions with the Society for Neuroscience and the DC-based start-up foundation FasterCures / The Center for Accelerating Medical Solutions, and is the recipient of two prestigious policy fellowships from the American Association for the Advancement of Science. Dr. Leitner received her PhD from Washington University in St. Louis where she was the recipient of a Howard Hughes Predoctoral Fellowship to study neuroscience and she graduated magna cum laude from Brown University with an Sc.B. in neuroscience.
ANDREA MARANO, Chief Financial Officer, is an assistant to the CEO at Enel SpA in Rome, former Assistant Vice President of the Capital Group Companies in London, Chartered Financial Analyst® Charterholder, and holds an MBA from the Harvard Business School and a B.S. in Business and Economics from Bocconi University in Italy.
DR. ANNABELLE SHEILA MENZIES, Ph.D., is Scientific Program Officer at Prize4Life. Sheila joined Prize4Life after completing a Postdoctoral Fellowship in the Department of Neurobiology at Harvard Medical School. She received her PhD from MIT, where her research focused on developmental neurobiology, and a BA in Biology from Queens College, City University of New York with a minor in Business and Liberal Arts.
RACHEL VON ROESCHLAUB is Prize4Life's Director of Business Development. After a brief career in professional tennis, Rachel worked as a molecular biologist at the Cold Spring Harbor Laboratory in New York, where she participated in cancer research and managed the Genome Facility. In 2003, she traveled to monasteries and schools in India to introduce Tibetan monks, students and teachers to modern Biotechnology. Her passion for science and art intertwined in 2003 as her paintings of biological themes were featured on the covers of leading industry magazines and journals. Rachel studied chemistry at the University of Montana and received an M.S. in organic chemistry from the University of Oregon.